Crinetics Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $3,885 | $143 | $1,031 | $361 |
Gross Profit | 4,344 | 143 | 1,031 | 361 |
EBITDA | -121,641 | -141,574 | -128,153 | -110,480 |
EBIT | -122,635 | -142,586 | -129,112 | -111,405 |
Net Income | -122,815 | -130,091 | -115,637 | -96,774 |
Net Change In Cash | 3,885 | 143 | 1,031 | 361 |
Free Cash Flow | -93,359 | -111,581 | -89,053 | -89,691 |
Cash | 101,536 | 110,901 | 53,726 | 94,569 |
Basic Shares | 94,057 | 94,215 | 93,791 | 93,102 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $7,696 | $1,039 | $4,013 | $4,737 |
Gross Profit | 2,730 | 1,039 | 4,013 | 4,737 |
EBITDA | -461,247 | -336,069 | -221,510 | -166,899 |
EBIT | -465,137 | -338,854 | -222,608 | -167,882 |
Net Income | -465,317 | -298,408 | -214,529 | -159,954 |
Net Change In Cash | 7,696 | 1,039 | 4,013 | 4,737 |
Free Cash Flow | -383,684 | -229,814 | -170,995 | -116,861 |
Cash | 101,536 | 264,545 | 54,897 | 32,671 |
Basic Shares | 94,057 | 80,783 | 58,071 | 51,982 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$1.29 |
2025-09-30 | -$1.38 |
2025-06-30 | -$1.23 |
2025-03-31 | -$1.04 |
